The short version of thymosin beta-4 fits in a sentence. The long version — which is the one that helps — is below.
This page was last updated on 2025-08-13 and is reviewed periodically as new material appears.
The molecule consists of 28 amino acid residues with an acetyl group attached to the N-terminal serine. Its sequence is acidic overall, with several glutamic and aspartic acid residues distributed along the chain and no cysteine, so disulfide bridges do not form. The peptide carries a net negative charge at physiological pH. Because the N-terminus is blocked, the intact molecule resists degradation by many aminopeptidases, which contributes to its stability in biological fluids.
The peptide is generated in cells by cleavage of prothymosin alpha, a larger acidic protein encoded by the PTMA gene. Prothymosin alpha is expressed in many tissues, not only in the thymus, and its functions include nuclear roles in chromatin-related processes. The 28-residue fragment corresponds to the N-terminal portion of that precursor. How the cleavage occurs and how the fragment's concentration is regulated remain open questions; circulating amounts are small and difficult to measure reliably with routine assays.
Thymosin alpha 1 is a synthetic 28-amino-acid peptide first isolated in 1966 from thymosin fraction 5, a bovine thymus extract. Its chain begins with an acetylated serine residue and ends with asparagine. The native peptide carries a molecular mass near 3,108 daltons. Researchers classify it as an immunomodulatory agent rather than a hormone with a single endocrine target. Early work framed it as a thymus-derived factor that supports T-cell maturation. The synthetic form used in research and clinical products matches the natural sequence.
Immune signaling studies link thymosin alpha 1 to Toll-like receptor pathways, particularly TLR2 and TLR9, on dendritic cells and other antigen-presenting cells. Activation of these receptors promotes maturation of T cells and increases natural killer cell activity. The peptide shifts cytokine output toward a T helper 1 profile, raising interferon gamma and interleukin 2 while modulating interleukin 10. Whether these effects translate into clinical benefit for any specific disease remains a subject of debate. Reported outcomes vary across trials and populations.
Thymosin alpha 1 is approved as a medicine in several countries, including Italy and China, for indications such as chronic hepatitis B and as an immune adjuvant. It is not approved by the United States Food and Drug Administration as a therapeutic product. In research settings the peptide appears in studies of sepsis, vaccine response, and oncology support, often with mixed or inconclusive results. The evidence base is uneven, and reviews note that many trials were small. Regulatory status therefore differs widely between jurisdictions.
| Property | Value | Notes |
|---|---|---|
| Chemical class | Acetylated peptide | N-terminal acetyl group blocks aminopeptidase attack |
| Residue count | 28 amino acids | Matches the N-terminus of prothymosin alpha |
| Molecular mass | About 3,108 Da | Value for the free, unmodified peptide |
| Isoelectric point | Approximately 4.2 | Acidic; net negative charge at neutral pH |
| Encoding gene | PTMA | Human gene for the precursor protein |
Thymosin alpha-1 is a 28-residue peptide first isolated from thymus tissue in the 1970s. It corresponds to the N-terminal portion of thymosin beta-4, from which it is cleaved in vivo. The peptide carries an acetyl group at its N-terminus, a modification that affects its charge and stability. Synthetic material produced by solid-phase peptide synthesis is chemically identical to the natural fragment and is the form used in research and clinical studies.
Laboratory work indicates that the peptide acts on cells of both the innate and adaptive immune systems. Reported effects include signalling through Toll-like receptors on dendritic cells, enhanced T-cell maturation, and increased natural killer cell activity. These actions are described largely from cell-culture and animal experiments, and the precise receptor-level events remain incompletely defined. Studies in humans have generally measured immune markers rather than a single defined molecular target. The resulting picture remains partly descriptive.
Clinical research has examined the peptide in chronic hepatitis B and C, as a vaccine adjuvant, and in sepsis and oncology settings. Results across trials have been mixed, and several studies were small or conducted under differing protocols. Regulatory status varies by country, and the compound is not approved in every jurisdiction where it is studied. Evidence for any single indication should be read with attention to sample size and endpoint choice.
Thymosin alpha-1 is a synthetic peptide of 28 amino acid residues that corresponds to a naturally occurring fragment first isolated from thymus tissue. Its chain is acetylated at the amino terminus, a modification that shields the peptide from rapid cleavage by aminopeptidases. The molecule carries a net negative charge at physiological pH and dissolves freely in water. Researchers classify it as an immune-modulating agent rather than a classical hormone, because it acts on several cell types of both the innate and the adaptive immune system.
The peptide was identified during work in the 1970s on thymosin fraction 5, a partially purified extract of calf thymus. Investigators separated that mixture and characterized individual components, one of which they named thymosin alpha-1. The same compound later received the international nonproprietary name thymalfasin. Commercial material is produced by solid-phase peptide synthesis rather than by extraction, so synthetic and natural forms share an identical sequence. Naming conventions vary across the literature, and readers should distinguish the alpha-1 peptide from other thymosins that have unrelated sequences and functions.
Eric Stephen Schmitt (born June 20, 1975) is an American attorney and politician serving since 2023 as the junior United States senator from Missouri. A member of the Republican Party, Schmitt served as the 46th state treasurer of Missouri from 2017 to 2019 and as the 43rd Missouri attorney general from 2019 to 2023. Schmitt began his political career as an alderman for Glendale, Missouri. From 2009 to 2017, he represented the 15th district in the Missouri Senate, during which he sponsored major reductions in the state income tax and franchise tax, and expanded benefits and tax exemptions for disabled citizens. As a state senator, Schmitt also led a bipartisan effort in response to the Ferguson unrest to successfully eliminate traffic ticket quotas and limit local revenues from non-traffic fines. In 2016, Schmitt was elected State Treasurer of Missouri. In 2018, Governor Mike Parson appointed Schmitt Missouri Attorney General. He was elected to a full four-year term as attorney general in 2020. As attorney general, he filed or joined lawsuits seeking to invalidate the Affordable Care Act, challenge the results of the 2020 presidential election (in Texas v. Pennsylvania), and, on 25 occasions, oppose the policies of the Joe Biden administration. He also sued school districts and municipalities for implementing mask requirements during the COVID-19 pandemic and sued the government of China and Chinese Communist Party for their alleged role in the pandemic. In 2022, Schmitt was elected to the U.S. Senate, defeating Democratic nominee Trudy Busch Valentine.
=== Ephedrine supplement ban === In response to renewed calls for the regulation of ephedra, the U.S. Department of Health and Human Services commissioned a large meta-analysis of ephedra's safety and efficacy by the RAND Corporation. This study found that ephedra promoted modest short-term weight loss, but there was insufficient data to determine whether it was effective for long-term weight loss or performance enhancement. The use of ephedrine alkaloids in this study was associated with significant gastrointestinal, psychiatric, and autonomic side effects. Almost simultaneously, a study in Annals of Internal Medicine found that ephedrine alkaloids were 100 to 700 times more likely to cause a significant adverse reaction than other commonly used supplements such as kava or Ginkgo biloba. On December 30, 2003, the FDA issued a press release recommending that consumers stop buying and using products containing ephedrine alkaloids, and indicating its intention to ban the sale of ephedrine alkaloid-containing supplements. Subsequently, on April 12, 2004, the FDA issued a final rule banning the sale of ephedrine alkaloid-containing dietary supplements. Tommy Thompson, the Secretary of Health and Human Services, stated that "...These products pose unacceptable health risks, and any consumers who are still using them should stop immediately." Products containing ephedra extract remain legal to this day.
constitutive expression 1. The continuous transcription of a gene, as opposed to facultative expression, in which a gene is only transcribed as needed. A gene that is transcribed continuously is called a constitutive gene. 2. A gene whose expression depends only on the efficiency of its promoter in binding RNA polymerase, and not on any transcription factors or other regulatory elements which might promote or inhibit its transcription.
Sources: en.wikipedia.org
== Cosmetic use == Copper peptide GHK-Cu is widely used in anti-aging and hair loss prevention cosmetics (INCI name: Copper tripeptide-1). Several controlled facial studies have shown anti-aging, firming and anti-wrinkle activity of copper peptide GHK-Cu, but with relatively small sample sizes and short duration of use, and further research is required to draw definitive conclusions.
== Interactions == If diazepam is administered concomitantly with other drugs, it is recommended that attention be paid to the possible pharmacological interactions. Particular care is taken with drugs that potentiate the effects of diazepam, such as barbiturates, phenothiazines, opioids, and antidepressants. Diazepam does not increase or decrease hepatic enzyme activity and does not alter the metabolism of other compounds. No evidence has suggested that diazepam alters its metabolism with chronic administration. Agents with an effect on hepatic cytochrome P450 pathways or conjugation can alter the rate of diazepam metabolism. These interactions would be expected to be most significant with long-term diazepam therapy, and their clinical significance is variable.
BCG has been one of the most successful immunotherapies. BCG vaccine has been the "standard of care for patients with bladder cancer (NMIBC)" since 1977. By 2014, more than eight different considered biosimilar agents or strains were used to treat nonmuscle-invasive bladder cancer.
Sources: en.wikipedia.org
The business was founded by Tim Horton, who played in the National Hockey League from 1949 until his death in an auto crash in 1974. The first Tim Horton restaurant was in North Bay, Ontario, and sold hamburgers. The chain's first donut store opened on May 17, 1964, in Hamilton, Ontario, under the name Tim Horton Donuts. The name was later abbreviated to "Tim Horton's" and then changed to "Tim Hortons" without the possessive apostrophe. Soon after Horton opened the store, he met Ron Joyce, a former police constable in Hamilton. In 1965, Joyce took over the fledgling Tim Horton Donut Shop at 65 Ottawa Street North. By 1967, after opening two additional stores, the two became full partners. Upon Horton's death in 1974, Joyce bought out the Horton family's shares for $1 million and took over as sole owner of the existing chain of 40 stores, quickly and aggressively expanding the chain in both geography and product selection. The 500th store opened in 1991. Joyce's aggressive expansion of the business resulted in major changes to the Canadian coffee and donut restaurant market. Many independent donut shops and small chains were driven out of business, while Canada's per-capita ratio of donut shops surpassed that of all other countries. The Horton and Joyce partnership carried on, with the marriage of Joyce's son, Ron Joyce Jr., and Horton's eldest daughter, Jeri-Lynn Horton-Joyce, who were joint owners of Tim Hortons franchises in Cobourg, Ontario, until 2023 when the couple retired after 37 years.
On July 9, Trump reversed a previously suspended military aid package to Ukraine following Russia's largest aerial assault on the country, involving hundreds of drones and missiles. The suspension, reportedly authorized by senior defense officials without Trump's prior knowledge. Trump expressed growing frustration with Russian president Vladimir Putin, accusing him of insincerity and relentless aggression, saying, "He wants to go all the way, just keep killing people, it's no good." The U.S. are discussing sending 10 Patriot missiles to Ukraine, and Trump said he is reviewing a proposed sanctions bill by Senator Lindsey Graham that would impose 500% tariffs on countries trading with Russia. Although Trump has previously mentioned secondary sanctions, none have been implemented so far, with the president citing their cost and waiting to see if a peace deal would emerge. On July 14, 2025, Trump threatened to impose 100% tariffs and secondary sanctions on countries purchasing Russian oil if Russia did not agree to a ceasefire within 50 days. Trump confirmed a summit meeting between him and Putin to be held on August 15, 2025, in Alaska The high-level summit at Joint Base Elmendorf–Richardson in Anchorage concluded without progress toward a ceasefire. Following the talks, Trump suggested the United States could assist Ukraine with surveillance flights or air defense support, while ruling out the deployment of ground troops.
The first known archaeological evidence of usage was in Kariandusi (Kenya) and other sites of the Acheulian age (beginning 1.5 million years BP) dated 700,000 BC, although only very few objects have been found at these sites relative to the Neolithic. Manufacture of obsidian bladelets at Lipari had reached a high level of sophistication by the late Neolithic, and was traded as far as Sicily, the southern Po river valley, and Croatia. Obsidian bladelets were used in ritual circumcisions and cutting of umbilical cords of newborns. Anatolian sources of obsidian are known to have been the material used in the Levant and modern-day Iraqi Kurdistan from a time beginning sometime about 12,500 BC. Obsidian artifacts are common at Tell Brak, one of the earliest Mesopotamian urban centers, dating to the late fifth millennium BC. Obsidian was valued in Stone Age cultures because, like flint, it could be fractured to produce sharp blades or arrowheads in a process called knapping. Like all glass and some other naturally occurring rocks, obsidian breaks with a characteristic conchoidal fracture. It was also polished to create early mirrors. Modern archaeologists have developed a relative dating system, obsidian hydration dating, to calculate the age of obsidian artifacts.
Sources: en.wikipedia.org
Thymosin fraction 5 is a mixture of many peptides obtained from thymus tissue, while thymosin alpha 1 is a single defined 28-residue molecule. The two names appear together in older literature because the purified peptide was first obtained from that mixture.
The precursor, prothymosin alpha, is encoded by the PTMA gene in humans. The 28-residue peptide corresponds to the N-terminal segment released from that larger protein.
It is produced as a fragment of prothymosin alpha and is present in many tissues. Circulating concentrations are low, which makes routine measurement difficult.
It is a chain of 28 amino acids, with an acetyl group attached to the first serine residue. The synthetic version replicates this sequence. Its molecular mass is about 3,108 daltons.